Bronchoprovocation Study to Demonstrate the Pharmacodynamic Bioequivalence of Albuterol Sulfate HFA Inhalation Aerosol (E.Q. 90 mcg of Albuterol Base/Inh) of Macleods Pharmaceuticals Ltd
Clinical trial NCT06618105 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06618105
- Sponsor
- Macleods Pharmaceuticals Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-15
- Primary completion
- 2025-05-31
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.